Genetic Screening Test Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols Vancouver, British Columbia–(Newsfile Corp. – January 14, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (FSE:...
Vancouver, British Columbia–(Newsfile Corp. – January 12, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing...
Vancouver, British Columbia–(Newsfile Corp. – January 11, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing...
Vancouver, British Columbia–(Newsfile Corp. – January 4, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing...
Vancouver, British Columbia–(Newsfile Corp. – December 25, 2020) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (“Entheon” or the “Company“) announces that it has closed a...
Vancouver, British Columbia–(Newsfile Corp. – December 18, 2020) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (“Entheon” or the “Company“) announces that it is proceeding with...
Vancouver, British Columbia–(Newsfile Corp. – December 9, 2020) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing...
Vancouver, British Columbia–(Newsfile Corp. – December 4, 2020) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing...
Vancouver, British Columbia–(Newsfile Corp. – December 1, 2020) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing...
Vancouver, British Columbia–(Newsfile Corp. – November 26, 2020) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (“Entheon” or the “Company”), a biotechnology company focused on developing...